SCHEMBL20335366

SCHEMBL20335366

CCCCCCc1ccc2ccc(O)cc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.65
CYP3A4 P08684 3/20 0.65
ESR1 P03372 2/20 0.65
ADRA2A P08913 2/20 0.65
ADORA3 P0DMS8 2/20 0.65
TACR2 P21452 2/20 0.65
SLC6A2 P23975 2/20 0.65
SLC6A4 P31645 2/20 0.65
SLC6A3 Q01959 2/20 0.65
TP53 P04637 2/20 0.65
KDM4E B2RXH2 1/20 0.65
ALDH1A1 P00352 1/20 0.65
LMNA P02545 1/20 0.65
SHBG P04278 1/20 0.65
HSPD1 P10809 1/20 0.65
ADRB3 P13945 1/20 0.65
HTR2C P28335 1/20 0.65
HSPE1 P61604 1/20 0.65
HIF1A Q16665 1/20 0.65
TST Q16762 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2050474 0.95 PTGS2 (0.67) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL2046991 0.95 PTGS2 (0.67) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL9698501 0.95 PTGS2 (0.67) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL2049841 0.95 PTGS2 (0.67) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL2047392 0.95 PTGS2 (0.67) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL9700041 0.95 PTGS2 (0.67) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL4065606 0.93 PTGS2 (0.63) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL18556121 0.89 PTGS2 (0.55) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL28134517 0.89 PTGS2 (0.55) PTGS2CYP3A4ESR1ADRA2AADORA3
SCHEMBL27519533 0.89 PTGS2 (0.55) PTGS2CYP3A4ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180248131-A1 ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME DIC CORPORATION (JP) 2018-08-30 US disclosed
EP-3342769-A1 ORGANIC COMPOUND, METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME DIC Corporation (JP) 2018-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180248131-A1 ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME TST, SOAT1, SOAT2 PTGS2 1309/4885CYP3A4 1111/4885ESR1 4237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.